Related Experiment Video
Updated: Aug 11, 2026
Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226
Published on: May 10, 2022
Defective expression of IL-2 receptors on peripheral blood lymphocytes from patients with cluster headache
P Martelletti1, G Stirparo, L De Stefano
1Headache Centre, Università La Sapienza, Rome, Italy.
Insights
Cluster headache patients show enhanced Natural Cytotoxic response after Interleukin-2 (IL-2) incubation. This study investigated the phenotypic expression of peripheral blood lymphocytes (PBL) and IL-2 receptors in these patients.
Area of Science:
- Immunology
- Neurology
Background:
- Cluster headache (CH) patients exhibit increased Natural Cytotoxic response.
- Interleukin-2 (IL-2) incubation of peripheral blood lymphocytes (PBL) enhances this response.
- Understanding IL-2 receptor expression is crucial for CH research.
Purpose of the Study:
- To investigate the phenotypic expression of PBL subsets before and after IL-2 incubation in CH patients.
- To analyze the expression of IL-2 receptors (CD25) on T-lymphocytes.
- To evaluate other cell surface markers including T-cells (CD3), NK cells (CD16), and lymphoblasts/monocytes (TFR).
Main Methods:
- Flow cytometry (FACS-420) was used to analyze PBL phenotypes.
- Peripheral blood lymphocytes from 23 episodic CH patients and 10 healthy controls were incubated with IL-2 (1,000 I.U./ml) for 72 hours.
- Monoclonal antibodies (MAbs) including anti-Leu-4 (CD3), anti-IL-2 receptors (CD25), anti-Transferrin receptor (TFR), and anti-Leu-11b (CD16) were utilized.
Main Results:
- The study evaluated changes in PBL phenotypic expression post-IL-2 incubation.
- Specific focus was placed on IL-2 receptor (CD25) expression on T-lymphocytes.
- Expression levels of CD3, CD16, and TFR were also assessed in CH patients compared to controls.
Conclusions:
- The findings provide insights into the immunological profile of cluster headache patients.
- Understanding lymphocyte responses to IL-2 may reveal new therapeutic targets.
- Further research is warranted to elucidate the role of these cellular changes in CH pathophysiology.
Abstract:
In a previous study we demonstrated that cluster headache (CH) patients present an increased Natural Cytotoxic response after incubation of their peripheral blood lymphocytes (PBL) with Interleukin-2 (IL-2). This phenomenon led to an investigation of the phenotypic expression of PBL before and after IL-2 incubation, and of the IL-2 lymphocyte receptor. IL-2 receptor is expressed on T-lymphocytes activated with an high-affinity binding site. The analysis of the function of human IL-2 receptor was facilitated by the production of a specific monoclonal antibody (MAb). This MAb identifies the IL-2 receptors by blocking the binding of radiolabelled IL-2 to T-cells. In addition, we studied the expression of Leu-4, specific for T-cells; of Leu-11b, specific for FC receptor on NK cells; and the Transferrin Receptor, specific for lymphoblasts and monocytes. Twenty-three episodic CH patients were selected for this study. Ten sex and age-matched healthy volunteers were used as the control group. We evaluated the PBL phenotypic expression of cells subsets before incubation with IL-2 (1,000 I.U./ml) and after 72 hours. The following Becton Dickinson MAbs have been used: anti-Leu-4 (CD3), anti-IL-2 receptors (CD25), anti-Transferrin receptor (TFR) and anti-Leu-11b (CD16). Indirect fluorescence with a Becton Dickinson FACS-420 flow cytometer was used to analyze the cells.(ABSTRACT TRUNCATED AT 250 WORDS)
